A 75-year-old patient with dementia and recurrent falls is prescribed risperidone 0.5mg BD by a psychiatrist for agitation and aggression. Which of the following is a crucial counselling point that must be discussed with the patient/carers regarding this prescription, according to NICE guidelines?